Crossing the borders of innovationBasing clinical trials on sound mechanistic and scientific rationale. Combating Pan-Cancer with PrecisionSaving Lives of Patients Who Exhausted Treatment Options and Improving Clinical BenefitsCancer Patients are fighting for their lives...we will fight with themImagining a world without cancer. Apollomics is an innovative biopharmaceutical company committed to the discovery and development of oncology combination therapies. Pipeline Science Events Our Vision To become a global leader in the development of novel medicines for cancer patients. Learn More Recent News February 11, 2021 Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China and South Africa February 10, 2021 Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater China More News
